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Cis-acting elements that regulate translation have been identified in the 39 noncoding regions (NCRs) of cellular and viral
mRNAs. As one means of analyzing the effect on translation of the conserved 39 terminal RNA structure of the West Nile virus
(WNV) genome, the translation efficiencies of chimeric mRNAs composed of a CAT reporter gene flanked by viral or nonviral
59 and 39 terminal sequences were compared. In vitro, the WNV 39(1) stem loop (SL) RNA reduced the translation efficiencies
of chimeric mRNAs with either viral or nonviral 59 NCRs, suggesting that a specific 39–59 RNA–RNA interaction was not
involved. In contrast, the 39 terminal sequence of a togavirus, rubella virus, enhanced translation efficiency. The WNV 39(1)SL
reduced translation efficiency both in cis and in trans and of both capped and uncapped chimeric mRNAs. We have previously
reported that three cellular proteins bind specifically to the WNV 39(1)SL RNA. Competition between the WNV 39(1)SL and
the 59 terminus of the chimeric mRNAs for proteins involved in translation initiation could explain the translation inhibition
observed. © 2001 Academic Press
Key Words: WNV 39 stem loop RNA; translation regulation; translation efficiency; coupled translation/transcription;
chimeric mRNAs.M
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The ;11-kb West Nile virus (WNV) genome is a single-
stranded, positive-polarity RNA that encodes a single
open reading frame (ORF) and is the only viral mRNA
(Chambers et al., 1990). Flanking the viral ORF are a
96-nucleotide (nt) 59 noncoding region (NCR) and a
32-nt 39 NCR. The members of the family Flaviviridae
are the only known animal positive-strand RNA viruses
that do not have a poly(A) tract at the 39 end of their
genomes (Wengler, 1981). The flavivirus 39 terminal se-
quence has been thermodynamically predicted and ex-
perimentally demonstrated to fold into a stable second-
ary structure (Brinton et al., 1986; Proutski et al., 1997;
Rauscher et al., 1997). The conformation and stability of
this structure are conserved among divergent flavivi-
ruses even though only short regions of the sequence
are conserved. The sequence adjacent to the terminal 39
stem loop (SL) has been predicted to form a small SL that
interacts with the terminal SL to form a pseudoknot (Shi
et al., 1996). When the 39 terminal sequence was deleted
or exchanged in a flavivirus infectious clone, no viable
virus was produced, indicating that this region contains
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49cis-acting elements required for virus replication (Men et
al., 1996; Zeng et al., 1998).
Although the members of two of the three genera,
Pestivirus and Hepacivirus, in the family Flaviviridae ini-
tiate translation from internal ribosomal entry site (IRES)
elements, the members of the genus Flavivirus utilize
cap-dependent translation. However, since flavivirus
genomic RNAs are not polyadenylated, a closed-loop
mRNA translation complex cannot be formed via interac-
tions between proteins binding to the 39 poly(A) and the
59 cap as occurs with cell mRNAs (Gale et al., 2000;
ichel et al., 2000). The 39 poly(A) tract binds to poly(A)-
inding protein (PABP), which interacts with eukaryotic
ranslation initiation factor 4F (eIF4F) and PABP-interact-
ng protein-1 (Paip-1). Paip-1 and eIF4F interact with
omponents of the cap-binding complex, such as eIF4G
nd eIF4A. The formation of a closed-loop complex in-
reases the stability of an mRNA and promotes efficient
ecruitment and recycling of ribosomes. Other RNA vi-
uses that do not have a 39 poly(A) on their mRNAs use
n alternative cell (Diez et al., 2000) or a viral (Vende et
l., 2000) 39 RNA-binding protein in place of PAPB to
ccomplish the 39–59 interactions. Translation regulation
ediated by RNA–RNA interactions between the 39 and
he 59 terminal regions of cell mRNAs has also been
roposed (Kozak, 1989; Sonenberg, 1994).
Cis-acting elements that regulate translation have
een mapped to the 39 NCRs of several positive-strand
iral RNA genomes. The rubella virus (RV) 39 terminal
equence (Pogue et al., 1993), the 39 NCR of tobacco
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50 LI AND BRINTONmosaic virus RNA (Leathers et al., 1993), and the 39 98
ucleotides (X region) of hepatitis C virus (Ito et al., 1998)
were reported to enhance the translation of chimeric
mRNAs or viral genomic mRNA in cis. Translation regu-
latory elements have also been reported in the 39 NCRs
of cellular mRNAs. For example, the addition of the 39
NCR of lipoprotein lipase mRNA to a heterologous re-
porter gene mRNA resulted in inhibition of reporter trans-
lation. Subsequent deletion of the first 50 (1601–1650)
nucleotides of this 39 NCR abrogated the translation
inhibition (Ranganathan et al., 1997). Likewise, the 39
AU-rich region of human beta-1 interferon mRNA (Grafi et
al., 1993), a short cis-acting element in the Xenopus FGF
receptor 39 NCR (Robbie et al., 1995), the 39 NCR of the
myocyte enhancer factor 2A (Black et al., 1997), and an
AU-rich element of the 39 NCR of tumor necrosis factor-a
(TNF-a) (Alonso et al., 1997; Gueydan et al., 1999) each
unctioned as cis-acting translational repressors in chi-
eric reporter mRNAs. Translational silencing is a
eans of posttranscriptionally regulating gene expres-
ion in cells. Cell proteins binding to regions within the
9 NCRs of certain cell mRNAs have been shown to
prevent their association with polysomes (Piecyk et al.,
2000), but the mechanism by which this is accomplished
is not yet known.
Although several previous studies have analyzed the
effect of the flavivirus 59 sequences on the translation
efficiencies of truncated genomic or chimeric mRNAs
(Cahour et al., 1995; Malet et al., 1998; Ruiz-Linares et al.,
1989), none of the mRNAs used in these studies con-
tained flaviviral 39 NCR sequences. This study is the first
to investigate a possible role for the flavivirus 39 terminal
SL in translation regulation. The effect of the WNV
genomic 39 terminal SL structure on the translation effi-
ciency of chimeric CAT mRNAs in cis and in trans was
analyzed. The results indicated that the WNV 39(1)SL
can function as a translational suppressor.
RESULTS
The effect of the WNV 39(1)SL in cis on the in vitro
translation efficiency of chimeric WNV/CAT mRNAs
Linear DNAs that contained CAT as a reporter gene
flanked by various 59 and 39 sequences were amplified
by PCR from plasmids constructed as described under
Materials and Methods. These chimeric PCR DNAs were
then transcribed in vitro into mRNAs with T7 RNA-depen-
dent RNA polymerase using a coupled transcription/
translation system as described under Materials and
Methods. Schematic diagrams of the various chimeric
RNAs synthesized are shown in Fig. 1. The 5912 and
5912/WNV39 mRNAs contained the entire WNV 59 NCR
and encoded a WNV/CAT fusion protein that consisted of
the first three amino acids of the WNV capsid protein
followed by the complete CAT sequence. The WNV cap-
sid sequence was included to complete the SL2 struc-ture. The 591 and 591/WNV39 mRNAs contained only the
WNV SL1 as their 59 NCR and encoded only the CAT
protein. All of these mRNAs contained 5 extra 59 nt,
59GGGCC39, which were obtained from the T7 promoter
and the adjacent ApaI cloning site. There were no extra
nucleotides at the 39 ends of the mRNAs synthesized. All
of the mRNAs shown in Fig. 1 also contained the 98-nt 39
NCR from pCM7 (Pharmacia). In chimeric mRNAs 5912
and 591, the pCM7 39 NCR was the 39 terminal sequence.
The 5912/WNV39 and 591/WNV39 mRNAs contained the
98-nt 39 NCR from pCM7 followed by the 39 terminal 96 nt
of the WNV genomic RNA [designated WNV 39(1)SL].
he WNV 39 sequence forms a conserved RNA structure
Brinton et al., 1986; Shi et al., 1996). The mRNAs tran-
scribed in the initial coupled in vitro transcription/trans-
lation assays were not capped so that the effect of the
WNV 39(1)SL on translation could be evaluated in the
absence of possible protein–protein interactions that
might facilitate a 59–39 interaction. Uncapped mRNAs
can be translated with reasonable efficiency in an in vitro
translation system (Ohlmann et al., 1995). However, cap-
ping increased the in vitro translation levels of the chi-
meric mRNAs by about four- to fivefold (see Fig. 3).
A preliminary experiment was done to determine
whether the efficiency of the transcription of mRNAs from
the different chimeric PCR DNA templates varied. The
transcribed mRNAs obtained at various times from the
transcription reactions were electrophoresed on 1% aga-
rose gels and the bands were quantified with a densi-
tometer after the gel was stained with ethidium bromide.
The amount of RNA transcribed from the different chi-
meric PCR DNA templates varied over a narrow range
(data not shown). Nevertheless, in all subsequent exper-
iments, both the amount of mRNA transcribed and the
amount of protein translated in the in vitro coupled tran-
scription/translation reactions were quantified to ensure
the accuracy of the translation efficiency calculations.
A representative gel containing the proteins translated
from the four chimeric mRNAs described above is shown
in Fig. 2A. A representative RNA gel is not shown. The
translation efficiency (TE) of 5912 RNA, which contains
the complete WNV 59 NCR, was set at 100% and the
translation efficiencies of the other RNAs were ex-
pressed relative to that of the 5912 mRNA. The 5912/CAT
and 591/CAT mRNAs were both translated relatively effi-
ciently (Fig. 2A, lanes 4 and 1, respectively). However,
deletion of SL2 in the 59 NCR, which shortened the 59
NCR by 29 nt, caused a 17% reduction in TE (Fig. 2B,
compare bars in lanes 4 and 1). The addition of the WNV
39(1)SL to the 39 termini of the chimeric mRNAs 5912/
WNV39 and 591/WNV39 significantly reduced their trans-
lation efficiencies, resulting in a decrease from 100 to
35% and from 83 to 27%, respectively (Fig. 2B, compare
bars in lanes 4 and 5 and bars in lanes 1 and 2, respec-
tively). An inhibitory effect by the WNV 39(1)SL in cis on
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different batches of rabbit reticulocyte lysates.
Comparison of the effect of the RV 39SL in cis on the
translation efficiencies of chimeric mRNAs
The 39 terminal sequence of the RV genomic RNA,
which included a SL and a 39 poly(A), was previously
reported to enhance the translation efficiency of chimeric
mRNAs (Pogue et al., 1993). However, the effect on trans-
lation of an RV 39 sequence without the poly(A) was not
tested. The presence of a 39 poly(A) tract on an uncapped
mRNA has been shown to stimulate translation and in-
crease stability (Gale et al., 2000; Vende et al., 2000). The
translation efficiencies of chimeric mRNAs with a 39 end,
consisting of the 39 terminal 87 nt of the rubella virus
genomic RNA and an 18-nt poly(A) tract, were compared
to those of chimeric mRNAs with either a 39 terminal
WNV 39SL or only the 98-nt NCR from pCM7 (Fig. 1).
A representative gel of proteins translated from these
chimeric mRNAs in an in vitro coupled transcription/
translation assay is shown in Fig. 2A. The 591/RV39 and
5912/RV39 mRNAs were translated more efficiently than
the 591 and 5912 mRNAs as indicated by an increase in
the TEs from 83 to 95% and from 100 to 115%, respec-
FIG. 1. Schematic representation of the chimeric mRNAs. The 5912/
dditional nt from the 59 end of the WNV capsid gene followed by the i
nd 591 RNAs, the 9-nt capsid sequence including the WNV initiation co
RNAs shown contained the 98-nt 39 NCR from plasmid pCM7. At the
erminal 96 nt of the WNV genomic RNA and the 5912/RV39 and 591/RV39
oly(A) tract.tively (Fig. 2B, compare bars in lanes 1 and 3 and bars inlanes 4 and 6, respectively). These data indicate that the
39 terminal sequences of WNV and RV differ significantly
in their effect on the in vitro translation efficiencies of the
chimeric mRNAs.
Effect of the WNV 39(1) RNA in cis on the in vitro
translation efficiency of a chimeric mRNA with a
nonviral 59 NCR
Two additional chimeric mRNAs, SD and SD/WNV39,
which had a 29-nt Shine–Dalgarno (SD) sequence as
their 59 NCR, were tested to determine whether the
presence of the WNV39 SL1 was required for the sup-
pression of translation by the WNV 39 SL. The translation
efficiencies of the SD chimeric mRNAs were compared
in an in vitro coupled transcription/translation assay. Fig-
ure 2C shows a representative protein gel. The amounts
of mRNA produced from the two DNA templates,
PCRT7SD/CAT and PCRT7SD/CAT/WNV39, varied within
a narrow range (data not shown). However, significantly
more protein was translated from the SD mRNA than
from the SD/WNV39 mRNA (Fig. 2C, lanes 3 and 2, re-
spectively). The addition of the WNV 39 SL RNA to the SD
mRNA 39 decreased the TE from 100 to 24% (Fig. 2D).
These data demonstrate that the WNV 59 NCR is not
, 5912/RV39, and 5912 RNAs included the WNV initiation codon and 9
CAT sequence minus its initiation codon. In the 591/WNV39, 591/RV39,
s deleted, but the CAT initiation codon was present. All of the chimeric
rminus, the 5912/WNV39, 591/WNV39, and SD/WNV39 RNAs had the 39
had the 39 terminal 100 nt of the RV genomic RNA as well as an 18-merWNV39
n-frame
don wa
ir 39 te
RNAsrequired for translation suppression by the WNV 39(1)SL.
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52 LI AND BRINTONEffect of the WNV 39(1)SL in cis on the in vitro
translation efficiencies of capped mRNAs
Since flavivirus genomic RNAs in infected cells have a
type 1 7mG cap that might participate in 39–59 interac-
tions, the translation efficiencies of capped chimeric
mRNAs were next compared. Type 1 cap, 7mG(5)9ppp(5)A9
0.25 mM; New England Biolabs), was added to each of the
oupled in vitro transcription/translation reactions. The
amounts of mRNA produced from the different DNA tem-
plates varied within a narrow range (data not shown).
Figure 3A shows a representative protein gel. As ex-
pected, all of the capped mRNAs were translated more
efficiently than the uncapped mRNAs. The translation
efficiency of capped 591 mRNA was four times higher
than that of uncapped 591 mRNA (Fig. 3B, compare lane
1 with lane 7), while the translation efficiency of capped
591/WNV39 was about three times more efficient than that
of uncapped 591/WNV39 mRNA (Fig. 3B, compare lane
2 with lane 8). Capping chimeric mRNAs that contained
FIG. 2. Effect of various 39 terminal sequences on the in vitro tran
ranslation products from chimeric mRNAs produced by in vitro coupled
ndicated mRNAs were labeled by incorporation of [35S]methionine and
osition of a protein marker is shown on the left side of the gel. (B) Rela
f protein translated by the amount of mRNA transcribed. The values u
elative TE represents the TE of a chimeric mRNA compared to that
utoradiograph of the labeled translation products produced from in
lanes 2 and 3, [35S]methionine-labeled proteins translated from SD/WN
The position of a protein marker is shown on the left side of the gel. (D
were averaged from three independent experiments. Relative TE reprethe RV 39 sequence increased their translation efficien-cies by about 4.7- to 5.6-fold (Fig. 3B, compare lane 3
with lane 9 and lane 6 with lane 10); a greater increase
in TE was observed for the 5912RV39 mRNAs that had a
longer 59 NCR (Fig. 3B, compare lanes 3 and 6).
As observed with uncapped mRNAs, the capped 591/
WNV39 and 5912/WNV39 mRNAs were translated less
efficiently than the 591 and 5912 mRNAs (decrease in TEs
from 71 to 22% and from 100 to 30%, respectively) (Fig.
3B, compare lane 1 with lane 2 and lane 4 with lane 5).
The presence of the WNV 39(1)SL in cis on capped
chimeric mRNAs reduced the translation efficiencies to a
greater degree than was observed for uncapped mRNAs
(2.5- to 2.8-fold for uncapped mRNAs as compared to 3.3-
to 3.4-fold for capped mRNAs) (Figs. 2B and 3B). In
contrast, the presence of the RV 39 sequence in cis
increased the translation efficiencies of capped mRNAs
1.5-fold (Fig. 3B, compare lane 1 with lane 3 and lane 4
with lane 6) compared to a 1.15- to 1.2-fold increase for
uncapped mRNAs (Fig. 2B). These data indicate that the
WNV 39 SL can suppress the translation of capped as
efficiency of uncapped chimeric mRNAs. (A) Autoradiograph of the
ription/translation reactions. Lanes 1 to 6, proteins translated from the
eparated by 10% SDS–PAGE; lane 7, no PCR DNA template added. The
of each chimeric mRNA. The TE was calculated by dividing the amount
calculate the TE were averaged from three independent experiments.
5912 mRNA. Error bars indicate the standard error of the mean. (C)
upled transcription/translation reactions. Lane 1, no template added;
RNA and SD mRNA, respectively, were separated by 10% SDS–PAGE.
tive TEs of the indicated mRNAs. The values used to calculate the TE
the TE of a chimeric mRNA compared to that of the SD mRNA.slation
transc
were s
tive TE
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V39 m
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53WNV 39 SL SUPPRESSES TRANSLATION OF CHIMERIC mRNAsThe effect of the addition of the WNV 39(1)SL RNA in
trans on the in vitro translation efficiency of capped
and uncapped chimeric mRNAs
To determine whether the WNV 39(1)SL RNA could
reduce the translation efficiencies of chimeric mRNAs
in trans, unlabeled WNV 39(1)SL RNA was synthesized
in vitro with T7 RNA polymerase as described under
Materials and Methods. Experiments were first done
with uncapped and then with capped chimeric mRNAs.
Different amounts (500 ng or 1 mg) of the WNV 39(1)SL
RNA were added to coupled in vitro transcription/
translation reactions concurrently with 0.5 mg of the
FIG. 3. Effect of various 39 terminal sequences on in vitro translation
products from chimeric mRNAs produced by in vitro coupled transcripti
f B. Lanes 1 to 6, capped chimeric mRNAs; lanes 7 to 10, uncapped c
he gel. (B) Relative TE of each chimeric mRNA. The values used to ca
E represents the TE of a chimeric mRNA compared to that of the caPCRT75912/CAT template PCR DNA. The uncappedmRNAs and proteins synthesized in the coupled reac-
tions were analyzed and the TEs were calculated. The
TE of the mRNAs in reactions containing no added
RNA was set at 100%. Figure 4A shows a representa-
tive protein gel. The addition of WNV 39(1)SL RNA in
trans did not significantly alter the amount of chimeric
mRNA transcribed (data not shown). However, addi-
tion of 0.5 mg of the 99-nt WNV 39(1)SL RNA (the 39
terminal 96 nt of the WNV genomic RNA and 3 Cs at
the 59 end from the T7 promoter) decreased the trans-
lation efficiency of the 5912/CAT mRNA from 100 to 30%
(Fig. 4B, compare lanes 1 and 2) and addition of 1 mg
ncy of capped chimeric mRNAs. (A) Autoradiograph of the translation
slation reactions. The names of the mRNAs are indicated at the bottom
mRNAs. The position of a protein marker is shown on the left side of
the TE were averaged from three independent experiments. Relative
912 mRNA. Error bars indicate the standard error of the mean.efficie
on/tran
himeric
lculate
pped 5of the WNV 39(1)SL RNA decreased the translation
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54 LI AND BRINTONefficiency of the 5912/CAT mRNA to 10% (Fig. 4B, com-
are lanes 1 and 3).
Capped chimeric mRNAs were also used in in trans
competition experiments. For these experiments, an in
itro transcribed 108-nt RV 39 RNA, which included the 87
erminal nt of the RV genome, an 18-nt poly(A), and 3 Cs
t the 59 end from the T7 promoter, was used as a
ontrol. Figure 4C shows a representative protein gel.
ddition of the WNV 39(1)SL (0.5 mg) reduced the trans-
ation efficiency of capped 59 12 mRNA from 100 to 42%
Fig. 4D, compare lane 1 with lane 2), while 1 mg of the
WNV 39(1)SL reduced the translation efficiency of this
mRNA to 16% (Fig. 4D, compare lane 1 with lane 3) and
5 mg of the WNV 39(1)SL reduced the translation of the
apped 59 12 mRNA to undetectable levels (Fig. 4B, lane
). In contrast, addition of the RV 39 RNA at the same
oncentrations had no effect on the translation efficiency
f the 59 12 mRNA (Fig. 4D, compare lane 1 with lanes 5,
, and 7). These results indicate that the WNV 39(1)SL
FIG. 4. Effect of addition of the WNV 39(1)SL in trans on the in v
utoradiograph of the translation products produced from uncapped 591
f different amounts of WNV 39(1)SL. (B) Relative TE of uncapped 5
ndependent experiments. Relative TE represents the TE of the 5912 m
RNA in the absence of any added 39 RNA. (C) Autoradiograph of the
ranscription/translation reactions in the presence of different amounts
alues used to calculate the TE were averaged from three independent
f an added 39 RNA compared to that of the 5912 mRNA in the absenNA can inhibit in vitro translation of the chimeric RNAsn trans as well as in cis and that this inhibitory effect is
ose dependent.
ffect of the WNV 39(1)SL in cis on the in vivo
ranslation efficiency of chimeric mRNAs
To test whether the inhibitory effect of the WNV
9(1)SL on translation of chimeric mRNAs could also be
etected in vivo, the PCR DNA templates were trans-
ected into BHK-21/W12 cells (referred to as BHK cells)
hat had been infected for 2 h with the vaccinia-T7 poly-
erase recombinant, vTF7-3 (Fuerst et al., 1986). This
vaccinia recombinant expresses T7 RNA polymerase as
well as cytoplasmic capping activity in infected cells
(Fuerst and Moss, 1989). Initial time course experiments
indicated that the maximum amount of CAT was pro-
duced between 18 and 24 h posttransfection (hpt) and
that the cytopathic effect (CPE) due to the vaccinia infec-
tion was first observed at 28 h postinfection. The amount
of RNA transcribed in vivo from each of the chimeric PCR
nslation efficiencies of capped and uncapped chimeric mRNAs. (A)
A by in vitro coupled transcription/translation reactions in the presence
NA. The values used to calculate the TE were averaged from three
the presence of added WNV 39(1)SL compared to that of the same
ation products produced from capped 5912 mRNA by in vitro coupled
V 39(1)SL or RV 39 RNAs. (D) Relative TE of capped 5912 mRNA. The
ents. Relative TE represents the TE of the 5912 mRNA in the presence
ny added 39 RNA.itro tra
2 mRN
912 mR
RNA in
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55WNV 39 SL SUPPRESSES TRANSLATION OF CHIMERIC mRNAsmg of total RNA extracted from cells at various times
posttransfection. The amount of protein translated from
each of the chimeric mRNAs in vivo was analyzed with
an anti-CAT ELISA. Figure 5A shows a representative
Northern blot of samples harvested at 24 h after trans-
fection (26 h after infection). The probe did not hybridize
with any of the control samples (Fig. 5A, lanes 1, 2, and
3). In vitro transcribed 5912/WNV39 mRNA was used as a
marker (Fig. 5A, lane 10).
Some variation in the amounts of chimeric mRNAs in
the individual cell extracts was observed and was most
likely due to variation in transfection efficiencies (Fig. 5A,
lanes 4 to 9). The TEs calculated for the various chimeric
mRNAs are shown in Fig. 5B. The TE of the 5912 mRNA
was set at 100% and the TEs of the other mRNAs were
expressed relative to that of the 5912 mRNA. As ob-
served in vitro, the presence of the RV39 terminus in
cis increased the TE of the chimeric mRNAs in vivo
(Fig. 5B). However, the increases observed in the TEs
for RV39-containing mRNAs in vivo were higher (1.7- to
1.95-fold) than those observed for the same capped
chimeric mRNAs in vitro (1.5-fold) (Figs. 3 and 5).
Although the TEs of chimeric mRNAs with a WNV
39(1)SL in cis were reduced in vivo, the degree of
translation suppression was less pronounced than
that observed for the same capped chimeric mRNAs in
FIG. 5. Effect of the various 39 NCR sequences on the translation ef
xtracted from T7 recombinant vaccinia virus-infected BHK cells 24 h af
NA-specific probe was used. Lane 1, RNA from mock-infected/nontra
NA from transfected/uninfected cells (T); lanes 4 to 9, RNA detected
0, in vitro transcribed 5912 mRNA (C). (B) The relative amount of WNV/
E represents the TE of a chimeric mRNA compared to that of the 59 12 m
xperiments.vitro (Figs. 3 and 5).DISCUSSION
The results indicate that the WNV 39(1)SL can function
as a translational suppressor of chimeric mRNAs both in
cis and in trans and that the WNV 59 NCR is not required
for this suppression. In contrast, the 39 sequence of
another positive-strand RNA virus, rubella, did not sup-
press the translation of chimeric mRNAs under the same
conditions, but enhanced translation. We have reported
previously that three cell proteins (p105, p84, and p52)
bind specifically and with high binding activity to the
WNV 39(1)SL (Blackwell and Brinton, 1995) and have
identified p52 as eukaryotic elongation factor 1-a (EF-1a)
(Blackwell and Brinton, 1997). The identities of p84 and
p105 are not yet known, but experiments are currently in
progress to identify these proteins. It is likely that the
suppressive effect of the WNV 39(1)SL on translation is
mediated by one or more of the cell proteins that bind to
it, since cell proteins that bind to the 39 NCRs of certain
ell mRNAs have been shown to be involved in transla-
ional silencing. In unstimulated cells, the cell protein
IAR (T cell intracellular antigen related) binds to an
U-rich element in the 39 NCR of the TNF-a mRNA and
uppresses its translation (Piecyk et al., 2000). Upon
treatment of the cells with lipopolysaccharides, a second
protein, p55, binds to the TNF-a mRNA 39 NCR and
overrides the translation suppressive effect of the bound
ies of chimeric mRNAs in vivo. (A) Northern blot analysis of total RNA
sfection with 5 mg of a chimeric PCR template DNA. A 32P-labeled CAT
d cells (M); lane 2, RNA from infected/nontransfected cells (I); lane 3,
ted cells that were transfected with the indicated template DNA; lane
CAT protein produced in vivo was assayed with a CAT ELISA. Relative
The TEs were calculated from values averaged from three independentficienc
ter tran
nsfecte
in infec
CAT or
RNA.TIAR (Gueydan et al., 1999). Proteins binding to the 39
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56 LI AND BRINTONNCR of the amyloid precursor protein mRNA suppress its
translation (Mbongolo Mbella et al., 2000). Although in
both examples cited, the data clearly show that specific
proteins binding to the 39 NCR are required for the
observed translational silencing, the mechanism by
which this suppression occurs is not yet known.
In infected cells, because RNA is transcribed from 59
to 39, the number of genomic 39(1)SLs would never be
expected to be in excess of the genomic 59 ends as was
he case in the in trans experiments. The observation
that the in trans suppression of in vitro translation by the
WNV 39(1)SL increased with increasing amounts of the
WNV 39(1)SL suggests that the WNV 39(1)SL might be
competing for a protein(s) in the lysate that is critical for
translation initiation or elongation. One possibility is that
one or both of the two as yet unidentified proteins that
bind to the WNV 39(1)SL could be involved in translation
initiation or elongation. Alternatively, since EF-1a shut-
tles charged tRNAs into the ribosome, it might be pos-
sible for EF-1a to shuttle the WNV 39(1)SL into the
ribosome, thus blocking the functioning of that ribosome.
Suppression of chimeric mRNA translation by the WNV
39SL was also observed in vivo but was less efficient.
he reason for this is not known. Cellular translation
actors and ribosomes are likely to be more abundant in
he cytoplasm of transfected cells than in the reticulocyte
xtracts and this would reduce the amount of suppres-
ion observed. Also, the intracellular environment in an
nfected cell is different from that in a transfected cell.
lavivirus RNA replication occurs in association with
erinuclear endoplasmic reticular membranes and ex-
ensive proliferation of these membranes is observed in
nfected cells (Rice, 1996). It is possible that translation
nitiation factors and/or ribosomes might be present at
ower concentrations in the viral RNA replication com-
artments than in the cytoplasm of infected cells. If this
s the case, then the viral 39 SL might more effectively
uppress translation in these compartments in infected
ells than in the cytoplasm of transfected cells.
The flavivirus genomic RNA, which is the only viral
RNA produced in infected cells, has a type 1 7mG cap
Rice, 1996). Comparison of the translation efficiencies of
apped and uncapped 5912 chimeric mRNAs in vitro
showed that capping provided a three- to fivefold in-
crease in translational efficiency (Fig. 5A). The presence
of a 59 cap increases the stability of cell mRNAs and
facilitates mRNA accessibility to translational initiation
factors (Gale et al., 2000). Uncapped mRNAs are initiated
by the same translational initiation factors but the asso-
ciation of these factors with uncapped mRNAs is weak.
The results of the present study indicate that the WNV
39SL suppressed the translation of both capped and
uncapped mRNAs and that the suppression of capped
mRNA translation was greater than that of uncapped
mRNA translation (Figs. 2 and 3).The current model for translation initiation of a cellmRNA suggests that the 39 and 59 ends of an mRNA are
brought into proximity during the formation of the trans-
lation initiation complex, forming a closed-loop complex.
The closed-loop complex is thought to increase the effi-
ciency of ribosome recruitment and ribosome recycling
(Jacobson and Peltz, 1996; Sachs et al., 1997; Gale et al.,
2000). For cell mRNAs, the closed-loop complex is
formed by interactions between PABP, which binds to the
39 poly(A), and components of the 59 cap-binding com-
plex, such as eIF-4G and Paip-1. Flavivirus genomic
RNAs do not have a 39 poly(A) and so cannot utilize PABP
to facilitate a 39–59 interaction. It was recently reported
that rotavirus mRNAs, which are also capped, but not
polyadenylated, form a closed-loop complex via the viral
protein, NSP3, which binds both to the 39 NCR of the viral
mRNA and to eIF-4G (Vende et al., 2000). The brome
mosaic virus genomic RNA is also capped, but not poly-
adenylated. The cell protein Lsm1p facilitates the inter-
action between the 39 NCR of this viral mRNA and com-
ponents of the 59 cap-binding complex (Diez et al., 2000).
The data obtained in the present study suggest that
cell proteins binding to the WNV 39SL do not facilitate
functional 39–59 interactions in chimeric mRNAs. A sig-
nificant increase in the translation efficiency of the chi-
meric mRNAs was observed both in vivo and in vitro
when a closed-loop complex could form, such as in the
case of the capped 591RV39 and 5912RV39 mRNAs that
contained a 39 poly(A) (Figs. 3 and 5). In contrast, a
decrease in the translation efficiency of capped chimeric
mRNAs that contained the WNV 39 SL was consistently
observed with both capped and uncapped mRNAs. It is
possible that a flaviviral protein could function like the
rotavirus NSP3 to facilitate a 39–59 interaction. No viral
proteins that bind to the 39 terminal region of the flavivi-
rus genomic RNA were detected in previous RNA–pro-
tein interaction studies done under stringent binding
conditions (Blackwell and Brinton, 1995). However, low-
activity binding of NS5 and NS3 to the 39 NCR has been
reported (Chen et al., 1997).
A 39–59 interaction in the flavivirus genomic RNA could
be facilitated by RNA basepairing rather than via the
interactions between proteins binding to the two ends of
the RNA. A previous report postulated that it was ther-
modynamically feasible for a conserved 39 8-nt se-
quence (CS1) located adjacent to the 39 SL to hybridize
with a complementary 8-nt sequence (59 CS) located in
he 59 capsid coding region (Hahn et al., 1987). Evidence
btained from an in vitro RNA replication system utilizing
engue replicons suggests that these sequences do pair
nd that this RNA–RNA interaction may be essential for
inus-strand RNA synthesis (You et al., 2001). The chi-
eric mRNAs used in the current study did not contain
ither the 39 or the 59 cyclization sequences. The effect of
hese sequences on the translation efficiency of chimeric
RNAs is currently under investigation.
Additional regions in viral RNA not included in the
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57WNV 39 SL SUPPRESSES TRANSLATION OF CHIMERIC mRNAschimeric mRNAs may be involved in enhancing transla-
tion. Evidence that some 59 flavivirus coding region se-
quences could enhance translation in vitro was reported
previously, but the mRNAs used in these studies did not
include viral 39 NCR sequences (Ruiz-Linares et al.,
1989). Proteins that interact with such enhancers may
regulate their function. In contrast to the results obtained
with the WNV 39 SL, which suppresses translation, the 39
NCR (X region) of the related hepatitis C virus RNA
enhances in vitro translation from an IRES (Ito et al.,
1998; Ito and Lai, 1999). A region that suppresses trans-
lation was identified in the capsid coding region of the
hepatitis C RNA. The reverse orientation, a 39 suppressor
and a 59 enhancer, appears to be the case for the
flavivirus members of the genus.
Since the flavivirus genomic RNA is not only an mRNA
but is also a template for RNA transcription, the proteins
binding to the 39 SL of the viral RNA may play a dual role
in suppressing translation and facilitating minus-strand
RNA transcription. Translation and transcription start at
opposite ends of the genome RNA and need to be
regulated so that “head-on” collisions between ribo-
somes and replication complexes do not occur. RNA–
RNA interactions as well as RNA–protein interactions
may be involved in regulating switching between a trans-
lation mode and a transcription mode. Further studies
are needed to identify and analyze the roles of additional
RNA elements and protein components that may be
involved in the regulation of flavivirus translation and
minus-strand transcription.
MATERIALS AND METHODS
Cells and virus
BHK-21/W12 cells (Vaheri et al., 1965) were used for in
T
List
Primer No.
1 59-CAGGAAACAGCTATGACCATG-39
2 59-CTTAGCACTAAGATCTCGATGGAGA
3 59-ATCCAGTGATTTTTTTCTCCATCGAG
4 59-AAGATCTCGATGTCTAAGAAAGAGA
5 59-ATATCCAGTGATTTTTTTCTCTTTCT
6 59-CACCCCGCGGCCGCTCCCATT-39
7 59-CCCAAGCTTCGCCATTTGCGCCCT
8 59-TCCCCGCGGTTTTTTTTTTTTTTTTTT
9 59-TCGACGAATTTCTGCCAT-39
10 59-AGTATCCTGTGTTCACGC-39
11 59-GGATCCTAATACGACTCACTATAGG
12 59-GGATCCTAATACGACTCACTATAGG
13 59-GGATAGTGTTCACCCTTG-39
14 59-GGATCCTAATACGACTCACTATAGG
15 59-GTTTTCCCAGTCACGAC-39
Note. Restriction enzyme sites are in boldface type, the T7 promotevivo experiments. Cells were grown in Dulbecco’s mini- umal essential medium (MEM) supplemented with 5%
heat-inactivated fetal bovine serum at 37°C in a CO2
atmosphere. BHK cells were infected with a recombinant
T7 vaccinia virus, vTF7-3 (Fuerst et al., 1986), to provide
source of intracellular T7 DNA-dependent RNA poly-
erase and cytoplasmic capping activity (Fuerst and
oss, 1989). The titer of vTF7-3 was determined by
laque assay on CV-1 cells. The WNV 39 and 59 terminal
sequences were amplified by RT-PCR from WNV, strain
E101 genomic RNA.
Preparation of oligonucleotides
The oligonucleotides used in this study are shown in
Table 1 and were synthesized on an Applied Biosystems
Model 381 DNA synthesizer in the DNA Core Facility of
the Biology Department of Georgia State University.
Plasmids and constructs
Plasmid pWNV59-CAT-WNV39 [which contained a T7
promoter, an ApaI site, the complete 96-nt WNV 59 NCR,
he 59 terminal 19 nt of the WNV capsid gene, a 37-nt SD
equence, the complete CAT coding region, the 98-nt
CM7 (Pharmacia) 39 NCR, the 39 terminal 96 nt of the
NV genomic RNA, and a SacII site] was previously
onstructed in plasmid PCR1000 (Invitrogen) (Blackwell
nd Brinton, unpublished data). Two plasmids, p591-CAT-
NV39 and p591 1 2-CAT-WNV39, were subcloned from
WNV59-CAT-WNV39 by deletion or addition of the appro-
riate sequences using sequential PCR (Sambrook et al.,
989). The first 59 105 nt of the WNV genomic RNA were
reviously predicted to fold into a conserved 59 terminal
L (SL1, 59 nt 1 to 76) followed by a smaller SL (SL2, 59 nt
7 to 105) (Brinton and Dispoto, 1988; Shi et al., 1996). To
onstruct p591-CAT-WNV39, a double PCR strategy was
ers
Sequence of the primer
ATCACTGGAT-39
AGTGCTAAG-39
ATCACTGGATAT-39
ATCGAGATCTT-39
-39
CTTCGACGAGATTTTCAGGAGCTAAAATGGAGAAAAAAATCACTGG-39
ACTCATCGCAGTACTGTTG-39
GGATAGACTAGGAGATCTTCT-39
nce is italicized, and the Shine–Dalgarno sequence is underlined.ABLE 1
of Prim
AAAAA
ATCTT
AAAAA
TAGAC
CCCAC
CT-39
GAAG
GGCC
GCCTGsed. The 39 and 59 PCR products were first amplified
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58 LI AND BRINTONusing primer sets 1/3 and 2/6 and then primers 1 and 6
were used to amplify the entire construct from the an-
nealed 39 and 59 PCR products. Primer 1 is the M13
reverse primer and annealed to a sequence 13 nt up-
stream of the T7 promoter. Primer 2 contained the
genomic 59 WNV sequence between nt 55 and 75 fol-
lowed by a tail containing the CAT 59 nt 1 to 22. Antisense
primer 3 was complementary to primer 2 and primed
within the CAT coding region. Primer 6 consisted of nt
1369 to 1396 in pPCR1000. The final PCR product was
digested with ApaI and SacII and cloned into similarly
digested pWNV59-CAT-WNV39 DNA. The resulting p591-
CAT-WNV39 contained the T7 promoter, the 59 terminal 76
nt of the WNV 59 NCR, the CAT gene beginning with its
initiation codon, the 98-nt pCM7 (Pharmacia) 39 NCR,
and the 39 terminal 96 nt of the WNV genomic RNA.
Using the same strategy, p591 1 2-CAT-WNV39 was
constructed with primer sets 1/5 and 4/6 (Table 1). Prim-
ers 1 and 6 were described above. Primer 4 contained
the WNV 59 genomic NCR sequence from nt 88 to 108
followed by a tail containing the 59 nt 4 to 24 of the CAT
coding region. Primer 5 was complementary to primer 4
and primed within the CAT coding region. p591 1 2-CAT-
WNV39 contained a T7 promoter, the first 59 105 nt of the
WNV genomic RNA (including the first 9 nt of the capsid
gene), the CAT coding region lacking its normal initiation
codon, the 98-nt pCM7 39 NCR, and the 39 terminal 96 nt
of the WNV genomic RNA.
Plasmids p591 1 2-CAT-RV39 and p591-CAT-RV39 were
constructed from p591 1 2-CAT-WNV39 and p59 1-CAT-
WNV39, respectively, by replacing the WNV 39 96 nt with
a 100-nt RV 39 terminal sequence followed by an 18-nt
poly(A) tail. The RV 39 terminal sequence was amplified
by PCR from pUC/59luc39 DNA (a gift from Dr. Nakhasi,
FDA, Bethesda, MD) with primer 7 and primer 8 (Table 1).
Primer 7 was located from nt 2215 to 2235 in pUC/
59luc39. Primer 8 was complementary to the sequence
from nt 2362 to 2380 in pUC/59luc39 and contained an
18-nt poly(A) tail followed by a SacII restriction enzyme
site and 3 extra nt to facilitate endonuclease digestion.
The PCR product was digested with HindIII and SacII
T
Synthesis of PCR Templates for in V
Plasmid template Reverse primer Forward
p591 1 2-CAT-WNV39 1 10
p591 1 2-CAT-RV39 1 8
p591 1 2-CAT-WNV39 1 9
p591-CAT-WNV39 1 10
p591-CAT-RV39 1 8
p591-CAT-WNV39 1 9
p591-CAT-WNV39 11 9
p591-CAT-WNV39 11 10and then cloned into similarly digested p591 1 2-CAT-WNV39 and p591-CAT-WNV39 DNA. The sequences of the
inserts in each of the plasmids constructed were verified
using an ABI Model 373A DNA sequencer (Georgia State
University Core Facility).
Linear DNA templates for in vitro coupled transcrip-
tion/translation reactions were amplified by PCR from the
four plasmids, p591 1 2-CAT-WNV39, p591-CAT-WNV39,
p591 1 2-CAT-RV39, and p591-CAT-RV39, using the primer
sets listed in Table 2 and Taq DNA polymerase (Pro-
mega). Primers 1 through 8 were described above.
Primer 9 annealed to the 39 end of the 98-nt pCM7 39
CR. Primer 10 annealed to the first 18 39 nt of the WNV
enomic RNA. Primer 11 contained a T7 promoter fol-
owed by a Shine–Dalgarno sequence and then the first
0 59 nt of the CAT gene. The various chimeric template
CR DNAs made as described above were resolved on
1% agarose gel. The bands were visualized by ethidium
romide staining and the DNA was purified from excised
ands using a Qiaquick PCR purification kit (Qiagen) and
uantified with a densitometer (Molecular Dynamics and
lphaInnotech Corp.). Different batches of these PCR
NA templates were used in the in vitro coupled tran-
cription/translation reactions and gave the same re-
ults.
A CAT RNA probe, which was complementary to the 39
alf of the coding region of the CAT mRNA, was used in
he Northern blots and was transcribed from the PCR
NA template PCRT7CAT. This template was amplified
rom p591-CAT-WNV39 DNA using primers 12 and 13
Table 1). The WNV39(1)SL RNA and the RV39 RNA that
were added to the coupled in vitro transcription/transla-
tion reactions to analyze their effect in trans on transla-
tion efficiencies were transcribed from the PCR DNA
templates PCRT7WNV39(1)SL and PCRT7RV39, respec-
tively. PCRT7WNV39(1)SL DNA was amplified from p591-
CAT-WNV39 using primers 14 and 10 (Table 1) and
PCRT7RV39 DNA was amplified from p591-CAT-RV39 us-
ing primers 15 and 8 (Table 1). The WNV39(1)SL RNA
contained the 39 terminal 96 nt of the WNV genomic RNA
and 3 Cs at the 59 end from the T7 promoter. The RV39
A Transcription from Plasmid DNAs
PCR product Corresponding mRNA
PCRT75912/CAT/WNV39 5912/WNV39
PCRT75912/CAT/RV39 5912/RV39
PCRT75912/CAT 5912
PCRT7591/CAT/WNV39 591/WNV39
PCRT7591/CAT/RV39 591/RV39
PCRT7591/CAT 591
PCRT7SD/CAT SD
PCRT7SD/CAT/WNV39 SD/WNV39ABLE 2
itro RN
primerRNA contained the 39 terminal 87 nt of the RV genome,
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59WNV 39 SL SUPPRESSES TRANSLATION OF CHIMERIC mRNAsan 18-nt poly(A) tail, and 3 extra Cs at the 59 end from the
T7 promoter.
In vitro coupled transcription/translation assays
The same molar amount of each chimeric DNA was
used as the template in a 25-ml in vitro coupled tran-
cription/translation reaction (TnT Coupled Reticulocyte
ysate System, Promega) performed according to the
anufacturer’s instructions. In some of the reactions, a
.25 mM concentration of type 1 cap, 7mG(5)9ppp(5)9A,
as added. Protein products were labeled by incorpora-
ion of [35S]methionine (1000 Ci/mmol; NEN). An aliquot
f each reaction was subjected to 10% SDS–PAGE. The
el was autoradiographed and the amount of radiola-
eled protein produced was quantified with a densitom-
ter. The remainder of the reaction mixture was treated
ith 20 U RNase-free DNase I (Boehringer Mannheim
iochemicals) for 15 min at 37°C. The volume of the
eaction was then increased to 50 ml. After phenol/chlo-
roform extraction an aliquot was electrophoresed on a
1% denaturing agarose gel. The RNA band was detected
after staining with ethidium bromide and was quantified
with a densitometer. The TE was calculated by dividing
the total amount of reporter protein translated by the total
amount of RNA transcribed.
In vitro transcription of the 32P-labeled CAT RNA
robe and unlabeled RNA transcripts
32P-labeled CAT RNA probe was transcribed in vitro at
37°C for 2 h in the presence of 40 mM Tris–HCl (pH 7.9),
6 mM MgCl2, 10 mM NaCl, 2 mM spermidine, 10 mM
dithiothreitol (DTT), 0.5 mM ribonucleotides (ATP, UTP,
CTP), 12 mM GTP, 50 mCi [32P]GTP (3000 Ci/mmol; NEN),
.1 ml T7 RNA polymerase (expressed and purified in the
laboratory, using a plasmid kindly provided by Dr.
Studier), 1.5 mg PCR product template DNA, and 20 U
Nasin (Boehringer Mannheim Biochemicals) in a final
eaction volume of 20 ml. Unlabeled RNAs were tran-
cribed in vitro at 37°C for 2 h in the presence of 40 mM
ris–HCl (pH 7.9), 6 mM MgCl2, 10 mM NaCl, 2 mM
permidine, 10 mM DTT, 0.25 mM ribonucleotides (ATP,
TP, CTP, and GTP), T7 RNA polymerase (either 0.2 ml of
7 polymerase made in the laboratory or 40 U of enzyme
rom Promega), 1.5 mg of PCR product template DNA, and
20 U RNasin (Boehringer Mannheim Biochemicals) in a
final reaction volume of 50 ml.
Transcribed RNA was ethanol precipitated and re-
solved by electrophoresis on a 6% urea–polyacrylamide
gel. The RNA band was detected by autoradiography or
by UV shadowing and excised. RNA was eluted from the
gel slice by overnight incubation at 60°C with rocking in
500 mM ammonium acetate, 1 mM EDTA, and 0.1% SDS.
The eluted RNA was filtered through a 0.45-mm cellulosecetate filter unit (Costar Co.) to remove residual gel Pieces, ethanol precipitated, resuspended in RNase-free
ater, and stored at 280°C.
n vivo translation assay
Confluent monolayers of BHK cells in 60-mm tissue
ulture dishes were infected at room temperature with
ecombinant T7 vaccinia virus at an m.o.i. of 10. One hour
ater the cells were washed once with serum-free MEM
nd then incubated at 37°C for 1 h in complete MEM.
he cells were then transfected with 5 mg of one of the
CR template DNAs for 3 h at 37°C using LipofectACE
Gibco BRL) according to the manufacturer’s instructions.
fter transfection, the cells were incubated at 37°C in a
O2 incubator until harvest at 24 h posttransfection. Viral
CPE was not observed until 28 h postinfection. Cells
were harvested by scraping. One-twentieth of each cell
sample was lysed with cytolysis buffer [10 mM HEPES
(pH 7.9), 5 mM DTT, 10 mM NaCl, 0.1 mM PMSF, 10 mg of
leupeptin (Boehringer Mannheim Biochemicals) per mil-
liliter, 1% Triton X-100, and 20% glycerol]. The cell lysates
were then centrifuged at 2000 g for 5 min at 4°C to
remove the nuclei and CAT and WNV/CAT proteins were
assayed by ELISA according to the manufacturer’s in-
structions (Boehringer Mannheim). The remaining cells
from each sample were used to assay chimeric mRNA
levels as described below.
RNA isolation and Northern blot analysis
Total RNA was isolated from the remainder of each
sample using Catrimox-14 according to the manufactur-
er’s instructions (Iowa Biotechnology Corp.) and the
amount of extracted total RNA was measured with a
spectrophotometer (Pharmacia Biotech) at OD260. Five
micrograms of the extracted total RNA was electropho-
resed on a 1% agarose gel and transferred to a Magna
nylon transfer membrane (Micro Separations, Inc.) using
the capillary transfer method (Sambrook et al., 1989). The
membrane was baked at 80°C for 2 h and then prehy-
bridized in 53 SSC containing 2 mM EDTA, 0.01% SDS,
200 mg/ml salmon sperm DNA, and 50% formamide for
2 h at 65°C. The CAT RNA probe (105 cpm), prepared as
escribed above, was then incubated with the mem-
rane at 65°C for 16 h. The membrane was sequentially
ashed three times for 10 min at 65°C with the solutions
3 SSC, 0.53 SSC, and 0.13 SSC and then autoradio-
raphed at 280°C.
reparation of figures
Autoradiographs of gels or membranes were scanned
ith an Arcus Agfa scanner. The digitalized images were
djusted using Adobe Photoshop (version 5.5) software
n a Macintosh G3 Power PC. The TEs were graphed
sing Microsoft Excel and then imported into Adobe
hotoshop.
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